Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Completed · Phase 2

Conditions studied: Lateral Canthal Lines, Crow's Feet, Facial Wrinkles

In brief

The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults.

Key facts

Study ID
NCT00888914
Run by
Revance Therapeutics, Inc.
People needed
60
Starts
2008-11-01
Expected to finish
2009-02-01
Last updated by the study team
2013-11-19

Who can join

Age: 30 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.